Foster Dykema Cabot & Partners’s iShares Ultra Short Duration Bond Active ETF ICSH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214M Buy
4,228,824
+74,100
+2% +$3.74M 12.43% 3
2026
Q1
$210M Buy
4,154,724
+128,873
+3% +$6.52M 13.38% 3
2025
Q4
$204M Buy
4,025,851
+1,846,242
+85% +$93.5M 12.51% 3
2025
Q3
$111M Sell
2,179,609
-41,152
-2% -$2.08M 7.26% 3
2025
Q2
$113M Sell
2,220,761
-30,890
-1% -$1.56M 7.92% 3
2025
Q1
$114M Buy
2,251,651
+71,169
+3% +$3.6M 9.16% 3
2024
Q4
$110M Buy
2,180,482
+1,346,255
+161% +$68M 8.57% 3
2024
Q3
$42.3M Sell
834,227
-11,487
-1% -$581K 3.55% 5
2024
Q2
$42.7M Buy
845,714
+40,616
+5% +$2.05M 3.82% 5
2024
Q1
$40.7M Sell
805,098
-195,852
-20% -$9.88M 3.79% 5
2023
Q4
$50.4M Buy
+1,000,950
New +$50.4M 5.34% 3

Other funds holding ICSH

Foster Dykema Cabot & Partners's ICSH Position: Q2 2026 in Review

Foster Dykema Cabot & Partners increased its iShares Ultra Short Duration Bond Active ETF (ICSH) stake by 1.8% in Q2 2026, buying an estimated $3.74M and bringing the position to 4,228,824 shares worth $214M. The position accounts for 12.43% of the portfolio, ranked #3.

Foster Dykema Cabot & Partners first reported a position in ICSH in Q4 2023 and has held it in 11 quarters since. 554 funds tracked by Wall St. Rank hold ICSH as of Q2 2026.

  • Foster Dykema Cabot & Partners held 4,228,824 shares of iShares Ultra Short Duration Bond Active ETF worth $214M as of Q2 2026.
  • Foster Dykema Cabot & Partners bought 74,100 iShares Ultra Short Duration Bond Active ETF shares in Q2 2026, an estimated $3.74M.
  • iShares Ultra Short Duration Bond Active ETF made up 12.43% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #3 holding.
  • Foster Dykema Cabot & Partners first reported a position in iShares Ultra Short Duration Bond Active ETF in Q4 2023 and has held it in 11 quarters since.
  • 554 funds tracked by Wall St. Rank held iShares Ultra Short Duration Bond Active ETF as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.